The University of Southampton
University of Southampton Institutional Repository

Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease

Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease
Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease
Objective: matrix metalloproteinase-9 (MMP-9) degrades type IV collagen, the major constituent of lung basement membrane. We studied the effects of chorioamnionitis and antenatal corticosteroids on bronchoalveolar lavage (BAL) fluid levels of MMP-9, and its inhibitor, TIMP-1 in preterm infants.
Study Design: a prospective study was performed on serial BAL samples from 79 ventilated preterm infants at less than 33 weeks' gestation, 18 of whom were from pregnancies complicated by chorioamnionitis. MMP-9 levels were measured by gelatin zymography and TIMP-1 by enzyme-linked immunosorbent assay, and the median value for each infant was calculated. The presence and severity of chorioamnionitis were defined histologically.
Results: BAL fluid MMP-9 levels were higher in preterm infants in the chorioamnionitis group (86 [29-518] vs 13 [3-43] ng/mL, P = .001), and levels increased stepwise with the increasing severity of chorioamnionitis. Antenatal corticosteroids had no effect on median MMP-9 levels. Infants in the chorioamnionitis group were more likely to have chronic lung disease (CLD) develop (55% vs 28%, P < .05). TIMP-1 levels were no different between groups.
Conclusion: chorioamnionitis is associated with increased lung type IV collagenase levels in the ventilated preterm infant. Antenatal lung inflammation with up-regulation of MMP-9 may be important in the pathogenesis of CLD.
preterm, antenatal corticosteroids, chorioamnionitis, matrix metalloproteinases, chronic lung disease
0002-9378
871-875
Curley, Anna E.
47295c33-cb7d-4db8-912c-3a4ea7c27224
Sweet, David G.
112c336e-2a4c-4198-b0cd-ab0bd6b359ef
Thornton, Claire M.
40dee9c5-6562-496e-b990-5199395b07d7
O'Hara, M. Denis
299206c6-4201-415f-a498-8a6110400aa3
Chesshyre, Emily
24da5239-f382-4159-9251-fa90d3673e34
Pizzotti, Jessica
90799a78-1e49-424e-b57a-21624bbc2eba
Wilbourn, Mark S.
a3f50d43-d1c5-4f79-83f4-d5055dbb323e
Halliday, Henry L.
5ec5d3b6-fc03-4410-96c2-3041ba1206fa
Warner, Jane A.
8571b049-31bb-4a2a-a3c7-4184be20fe25
Curley, Anna E.
47295c33-cb7d-4db8-912c-3a4ea7c27224
Sweet, David G.
112c336e-2a4c-4198-b0cd-ab0bd6b359ef
Thornton, Claire M.
40dee9c5-6562-496e-b990-5199395b07d7
O'Hara, M. Denis
299206c6-4201-415f-a498-8a6110400aa3
Chesshyre, Emily
24da5239-f382-4159-9251-fa90d3673e34
Pizzotti, Jessica
90799a78-1e49-424e-b57a-21624bbc2eba
Wilbourn, Mark S.
a3f50d43-d1c5-4f79-83f4-d5055dbb323e
Halliday, Henry L.
5ec5d3b6-fc03-4410-96c2-3041ba1206fa
Warner, Jane A.
8571b049-31bb-4a2a-a3c7-4184be20fe25

Curley, Anna E., Sweet, David G., Thornton, Claire M., O'Hara, M. Denis, Chesshyre, Emily, Pizzotti, Jessica, Wilbourn, Mark S., Halliday, Henry L. and Warner, Jane A. (2003) Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease. American Journal of Obstetrics and Gynecology, 188 (4), 871-875. (doi:10.1067/mob.2003.215).

Record type: Article

Abstract

Objective: matrix metalloproteinase-9 (MMP-9) degrades type IV collagen, the major constituent of lung basement membrane. We studied the effects of chorioamnionitis and antenatal corticosteroids on bronchoalveolar lavage (BAL) fluid levels of MMP-9, and its inhibitor, TIMP-1 in preterm infants.
Study Design: a prospective study was performed on serial BAL samples from 79 ventilated preterm infants at less than 33 weeks' gestation, 18 of whom were from pregnancies complicated by chorioamnionitis. MMP-9 levels were measured by gelatin zymography and TIMP-1 by enzyme-linked immunosorbent assay, and the median value for each infant was calculated. The presence and severity of chorioamnionitis were defined histologically.
Results: BAL fluid MMP-9 levels were higher in preterm infants in the chorioamnionitis group (86 [29-518] vs 13 [3-43] ng/mL, P = .001), and levels increased stepwise with the increasing severity of chorioamnionitis. Antenatal corticosteroids had no effect on median MMP-9 levels. Infants in the chorioamnionitis group were more likely to have chronic lung disease (CLD) develop (55% vs 28%, P < .05). TIMP-1 levels were no different between groups.
Conclusion: chorioamnionitis is associated with increased lung type IV collagenase levels in the ventilated preterm infant. Antenatal lung inflammation with up-regulation of MMP-9 may be important in the pathogenesis of CLD.

Full text not available from this repository.

More information

Published date: April 2003
Keywords: preterm, antenatal corticosteroids, chorioamnionitis, matrix metalloproteinases, chronic lung disease

Identifiers

Local EPrints ID: 45461
URI: https://eprints.soton.ac.uk/id/eprint/45461
ISSN: 0002-9378
PURE UUID: db27a5ae-1613-418d-a94a-b810f58a5245

Catalogue record

Date deposited: 30 Mar 2007
Last modified: 13 Mar 2019 21:05

Export record

Altmetrics

Contributors

Author: Anna E. Curley
Author: David G. Sweet
Author: Claire M. Thornton
Author: M. Denis O'Hara
Author: Emily Chesshyre
Author: Jessica Pizzotti
Author: Mark S. Wilbourn
Author: Henry L. Halliday
Author: Jane A. Warner

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×